Robert Kristal
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | BioRestorative Therapies, Inc. (BRTX) | Chief Financial Officer | $293,752 | $683,752 |
| 2023 | BioRestorative Therapies, Inc. (BRTX) | Chief Financial Officer | $240,624 | $618,124 |
| 2022 | BioRestorative Therapies, Inc. (BRTX) | Chief Financial Officer | $175,000 | $175,000 |
| 2021 | BioRestorative Therapies, Inc. (BRTX) | Chief Financial Officer | $29,166 | $82,383 |
Executive changes
Earnings-call appearances
-
BioRestorative Therapies, Inc. Q1 FY2025 Earnings Call2025-05-14
BioRestorative Therapies, Inc. (BRTX)
-
BioRestorative Therapies, Inc. Q2 FY2024 Earnings Call2024-08-06
BioRestorative Therapies, Inc. (BRTX)
-
BioRestorative Therapies, Inc. Q1 FY2024 Earnings Call2024-03-31
BioRestorative Therapies, Inc. (BRTX)